You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • THU0286 Immunologic Response to Long-Term Epratuzumab Treatment in Sl0008, An Open-Label Long-Term Extension Study in Patients with Moderate-to-Severe Systemic Lupus Erythematosus

Article metrics

Article menu
Download PDFPDF
Poster Presentation
SLE, Sjögren’s and APS - treatment
THU0286 Immunologic Response to Long-Term Epratuzumab Treatment in Sl0008, An Open-Label Long-Term Extension Study in Patients with Moderate-to-Severe Systemic Lupus Erythematosus

 

Online download statistics by month:

Online download statistics by month: February 2014 to December 2023

AbstractFullPdf
Feb 2014101
Mar 2014200
Apr 2014500
May 2014500
Jun 2014300
Jul 2014100
Sep 2014200
Oct 2014300
Nov 2014400
Dec 2014200
Jan 2015200
Feb 2015300
Mar 2015801
Apr 2015400
Jul 2015300
Aug 2015300
Sep 2015400
Oct 2015200
Nov 2015400
Jan 2016200
Mar 2016200
May 2016600
Jun 2016200
Jul 2016400
Aug 2016200
Sep 2016700
Oct 2016300
Nov 2016200
Dec 2016500
Jan 2017501
Feb 2017300
Mar 2017900
Apr 2017600
May 2017900
Jun 2017600
Jul 20171400
Aug 20171400
Sep 2017600
Oct 2017400
Nov 20173800
Dec 20176600
Jan 20185000
Feb 20182400
Mar 20183800
Apr 20184200
May 20188001
Jun 20181200
Jul 20181200
Aug 20181200
Sep 20181000
Oct 20181200
Nov 20182000
Dec 20181800
Jan 20192000
Feb 20191800
Mar 2019200
Apr 2019200
May 2019200
Dec 2019200
Jan 2020200
Feb 2020400
Apr 2020200
Jul 2020200
Aug 2020001
Sep 2020600
Nov 2020400
Dec 20201800
Jan 20211000
Apr 2021200
Jun 2021100
Oct 2021400
Nov 2021600
Dec 2021700
Feb 2022400
Mar 2022600
Apr 2022400
May 2022400
Jul 20221000
Aug 20221400
Sep 2022600
Oct 2022200
Nov 2022200
Dec 2022600
Jan 20231600
Feb 2023400
Mar 2023400
May 2023400
Jul 2023200
Sep 2023800
Oct 2023201
Nov 2023200
Dec 2023600
Total82606